| Symbol | SEER |
|---|---|
| Name | SEER, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 3800 BRIDGE PARKWAY,SUITE 102, REDWOOD CITY, California, 94065, United States |
| Telephone | +1 650 453-0000 |
| Fax | — |
| — | |
| Website | https://www.seer.bio |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001726445 |
| Description | Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Additional info from NASDAQ: |
Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
Read moreSeer to Participate in the Canaccord Genuity 46th Annual Growth Conference
Read moreSEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with SBS Law
Read moreSeer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
Read moreRoelofs Nicolas H PHD 🟢 acquired 41.5K shares (1 derivative) of Seer, Inc. (SEER) at $2.14 Transaction Date: Jul 28, 2026 | Filing ID: 000002
Read moreRo Isaac 🟢 acquired 31.1K shares (1 derivative) of Seer, Inc. (SEER) at $2.14 Transaction Date: Jul 28, 2026 | Filing ID: 000002
Read more